| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0009 |
| mRNA | WP1130 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.001 |
| mRNA | navitoclax:piperlongumine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.13 | 0.001 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | 0.15 | 0.001 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.13 | 0.001 |
| mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.001 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | 0.14 | 0.002 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | -0.13 | 0.002 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.002 |